Long ‐term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma
ConclusionsStereotactic body radiotherapy was effective for patients with small hepatocellular carcinomas who were ineligible for resection or ablation therapies. The incidence of grade 3 or higher adverse effects did not increase even after longer follow‐up times.
Source: Hepatology Research - Category: Internal Medicine Authors: Katsumaro Kubo, Tomoki Kimura, Hiroshi Aikata, Shigeo Takahashi, Yuki Takeuchi, Ippei Takahashi, Ikuno Nishibuchi, Yuji Murakami, Kazuaki Chayama, Yasushi Nagata Tags: Original Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Internal Medicine | Liver | Liver Cancer | Study | Toxicology | Urology & Nephrology